Melanoma Podcasts Melanoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Promising biomarkers to select patients for checkpoint inhibitor therapy in melanoma
Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, gives an overview of the use of biomarkers to select patients for checkpoint inhibitor therapy in melanoma at ... Author: VJOncology Added: 02/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 23, 2017 Category: Cancer & Oncology Source Type: podcasts

Neoadjuvant therapy in bulky Stage III melanoma
Georgina Long, MD, PhD, from the University of Sydney, Sydney, Australia, gives an overview of her talk on neoadjuvant therapy in bulky Stage III melanoma at the European Cancer Congress of the Europe... Author: VJOncology Added: 02/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Combined treatment with BRAF and MEK inhibitors in metastatic melanomas with BRAF mutations
Rodabe N. Amaria, MD from the University of Texas MD Anderson Cancer Center, Houston, TX gives an overview on the benefits of combined treatment with BRAF and MEK inhibitors for metastatic melanoma at... Author: VJOncology Added: 02/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Developments in melanoma new treatment options
Dirk Schadendorf, MD, PhD, from the University Hospital Essen, Essen, Germany, discusses developments in melanoma treatment at the European Cancer Congress of the European Cancer Organisation (ECCO) 2... Author: VJOncology Added: 02/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 17, 2017 Category: Cancer & Oncology Source Type: podcasts

Neoadjuvant therapy with trametinib and dabrafenib in high risk resectable BRAF-mutant melanoma
Rodabe N. Amaria, MD from the University of Texas MD Anderson Cancer Center, Houston, TX summarizes results on a recent randomized Phase II clinical trial of neoadjuvant treatment with BRAF and MEK in... Author: VJOncology Added: 02/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 16, 2017 Category: Cancer & Oncology Source Type: podcasts

Benefits and risks of treatment with ipilimumab after complete resection of Stage III melanoma
Dirk Schadendorf, MD, PhD, from the University Hospital Essen, Essen, Germany, discusses the risks and benefits of adjuvant ipilimumab treatment after complete resection of Stage III melanoma based on... Author: VJOncology Added: 02/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 16, 2017 Category: Cancer & Oncology Source Type: podcasts

Big News: Adjuvant Ipi Improves Survival in Melanoma
Dr Caroline Robert reviews melanoma highlights from ESMO 2016, focusing on results of ipilimumab in the adjuvant setting and the highest 3-year survival achieved in metastatic disease. (Source: Medscape Oncology)
Source: Medscape Oncology - October 17, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Open questions in the dermatopathology of cutaneous tumors - desmoplastic melanoma, spitzoid melanocytic neoplasms and Merkel cell carcinoma
Martin Mihm, Jr., MD of Brigham and Women's Hospital, Boston, MA gives an overview of the session on open quesions in dermatopahtology of cutaneous tumors held at the World Congress on Cancers of the ... Author: VJOncology Added: 10/06/2016 (Source: Oncology Tube)
Source: Oncology Tube - October 6, 2016 Category: Cancer & Oncology Source Type: podcasts

Treating early stage melanoma
Jean-Jacques Grob, MD of Aix Marseille University and APHM Hospital CHU Timone, Marseille, France discusses the idea of focussing on treating melanoma patients during earlier stages of disease at the ... Author: VJOncology Added: 10/06/2016 (Source: Oncology Tube)
Source: Oncology Tube - October 6, 2016 Category: Cancer & Oncology Source Type: podcasts

What to do with BRAF-mutant melanoma patients who have a poor prognosis?
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, suggests next steps for poor prognosis BRAF-mutant melanoma patients with elevated lactate dehydr... Author: VJOncology Added: 10/06/2016 (Source: Oncology Tube)
Source: Oncology Tube - October 6, 2016 Category: Cancer & Oncology Source Type: podcasts

The current status and future of vaccinations for melanoma
"Brigitte Drno, MD, PhD of the University Hospital of Nantes, Nantes, France discusses vaccinations for melanoma and the decrease in the number of clinical trials being carried out. She explains the ... Author: VJOncology Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Melanoma immunotherapy updates in 2016: clinical trials, developments and new survival data
Jeffrey Weber, MD, PhD of the NYU Langone Medical Center, New York, NY, discusses his satellite symposium talk on updates in melanoma immunotherapy at the 2016 World Congress of Cancers of the Skin (W... Author: VJOncology Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts

How best to treat NRAS-mutated melanoma
Jean-Jacques Grob, MD of the Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France, discusses treatments for melanoma patients with NRAS mutation at the 2016 World Congress on Cance... Author: VJOncology Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Using biomarkers to predict response to combination therapies in BRAF-mutant melanoma
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the two currently approved combination therapies used for treating BRAF-mutant melanoma... Author: VJOncology Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Mechanisms of resistance to checkpoint inhibitors in melanoma
Paolo Ascierto, MD of the National Tumor Institute Fondazione G. Pascale, Naples, Italy provides an overview of his talk on the mechanisms of resistance against checkpoint inhibitors in melanoma at th... Author: VJOncology Added: 09/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2016 Category: Cancer & Oncology Source Type: podcasts